shRNA-mediated stable knockdown of BTF3 in PC-3 and DU145 cells resulted in significantly reduced percentage of BrdU positive cells (Fig. 3a), a marker of replicative DNA synthesis in S-phase, consistent with a role for BTF3 in DNA replication in prostate cancer cells. Here, BTF3 is linked to prostate carcinoma.